EUVIMEDDescoperă EUVIMED
Crossref

Suppression of MAPK / NF‐kB and activation of Nrf2 signaling by Ajugarin‐I in EAE model of multiple sclerosis

Adnan Khan, Bushra Shal, Ashraf Ullah Khan, Tehmina Bibi, Sara Zeeshan, Syeda Saniya Zahra, Phillip Crews, Ihsan Ul Haq, Fakhar Ud Din, Hussain Ali, Salman Khan iD

Phytotherapy Research · 2023-06 · 37 (6) · 2326-2343

DOI: 10.1002/ptr.7751 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2023-02-15. Written by Adnan Khan and 10 co-authors. Institution: Pharmacological Sciences Research Lab, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan. Major MEDLINE topics: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Cited 19 times so far (Crossref); 78 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Multiple sclerosis (MS) is a debilitating neurodegenerative autoimmune disease of the central nervous system (CNS). The current study aimed to investigate the neuroprotective properties of Ajugarin‐I (Aju‐I) against the experimental autoimmune encephalomyelitis (EAE) model of MS and explored the underlying mechanism involved. The protective potential of Aju‐I was first confirmed against glutamate‐induced HT22 cells and hydrogen peroxide (H 2 O 2 )‐induced BV2 cells. Next, an EAE model has been established to investigate the mechanisms of MS and identify potential candidates for MS treatment. The behavioral results demonstrated that Aju‐I post‐immunization treatment markedly reduced the EAE‐associated clinical score, motor impairment, and neuropathic pain. Evans blue and fluorescein isothiocyanate extravasation in the brain were markedly reduced by Aju‐I. It effectively restored the EAE‐associated histopathological changes in the brain and spinal cord. It markedly attenuated EAE‐induced inflammation in the CNS by reducing the expression levels of p‐38/JNK/NF‐κB but increased the expression of IkB‐α. It suppressed oxidative stress by increasing the expression of Nrf2 but decreasing the expression of keap‐1. It suppressed EAE‐induced apoptosis in the CNS by regulating Bax/Bcl‐2 and Caspase‐3 expression. Taken together, this study suggests that Aju‐I treatment exhibits neuroprotective properties in the EAE model of MS via regulation of MAPK/NF‐κB, Nrf2/Keap‐1, and Bcl2/Bax signaling.

Subjects

MeSH terms (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsMiceNF-kappa BNF-E2-Related Factor 2bcl-2-Associated X ProteinMice, Inbred C57BL

Author keywords

Ajugarin-IBcl2/Caspase-3EAEMAPK/NF-κBNrf2/Keap-1multiple sclerosis

Substances

NF-kappa BNF-E2-Related Factor 2bcl-2-Associated X Protein

Authors and institutions

  • Pharmacological Sciences Research Lab, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • DHQ Teaching Hospital Timergara, Lower Dir, Timergara, Pakistan.
  • Department of Pharmaceutical Sciences, Pak-Austria Fachhochschule Institute of Applied Sciences and Technology, Haripur, Pakistan.
  • Faculty of Pharmaceutical Sciences, Abasyn University, Peshawar, Pakistan.
  • Division of Physical Sciences, Department of Chemistry and Biochemistry, University of California, Santa Cruz, California, USA.

ORCID profiles: Salman Khan

Cite

APA

Khan, A., Shal, B., Khan, A. U., Bibi, T., Zeeshan, S., Zahra, S. S., Crews, P., Haq, I. U., Din, F. U., Ali, H., & Khan, S. (2023). Suppression of MAPK / NF‐kB and activation of Nrf2 signaling by Ajugarin‐I in EAE model of multiple sclerosis. Phytotherapy Research, 37(6), 2326-2343. https://doi.org/10.1002/ptr.7751

Vancouver

Khan A, Shal B, Khan AU, Bibi T, Zeeshan S, Zahra SS, et al. Suppression of MAPK / NF‐kB and activation of Nrf2 signaling by Ajugarin‐I in EAE model of multiple sclerosis. Phytotherapy Research. 2023;37(6):2326-2343. doi:10.1002/ptr.7751

BibTeX
@article{Khan2023,
  author = {Khan, Adnan and Shal, Bushra and Khan, Ashraf Ullah and Bibi, Tehmina and Zeeshan, Sara and Zahra, Syeda Saniya and Crews, Phillip and Haq, Ihsan Ul and Din, Fakhar Ud and Ali, Hussain and Khan, Salman},
  title = {Suppression of MAPK / NF‐kB and activation of Nrf2 signaling by Ajugarin‐I in EAE model of multiple sclerosis},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {6},
  pages = {2326--2343},
  doi = {10.1002/ptr.7751}
}
Start for free →